tirzepatide launch date Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Zepbound (tirzepatide) FDA Approval History

From the tube, Berry Boost is a deep berry shade that I really liked

In December 2025, the administration also introduced the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) model, a five year CMS Innovation Center (CMMI) model that intends to expand access to obesity drugs in Medicaid and Medicare by negotiating lower GLP-1 prices with manufacturers

Stronger Together, Healthier Every Day Join our Facebook community and connect with others on the same wellness journey sharing support, insights, and real results with guidance from the MD Meds team

Non-drug interventions such as bariatric surgery and lifestyle changes also serve as alternatives